Related Experiment Video
Updated: Jun 23, 2026

Scanning Electron Microscopy of Macerated Tissue to Visualize the Extracellular Matrix
Published on: June 14, 2016
Skeletal muscle expression and abnormal function of beta-myosin in hypertrophic cardiomyopathy
G Cuda1, L Fananapazir, W S Zhu
1Laboratory of Molecular Cardiology, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, Maryland 20892.
Insights
Genetic mutations in the beta-myosin heavy chain (beta-MHC) gene cause hypertrophic cardiomyopathy. These mutations lead to abnormal protein interactions in muscle, affecting function.
Area of Science:
- Cardiovascular Genetics
- Molecular Cardiology
- Inherited Cardiomyopathies
Background:
- Hypertrophic cardiomyopathy (HCM) is a significant inherited cardiac condition.
- The beta-myosin heavy chain (beta-MHC) gene is implicated in some HCM cases.
- Understanding the molecular basis of HCM is crucial for diagnosis and treatment.
Purpose of the Study:
- To investigate the expression of mutant beta-MHC gene in skeletal muscle of HCM patients.
- To determine the functional consequences of beta-MHC gene mutations on myosin function.
- To confirm the role of missense mutations in the beta-MHC gene in HCM etiology.
Main Methods:
- Utilized missense and silent mutations in the beta-MHC gene as genetic markers.
- Demonstrated the presence of mutant and normal cardiac beta-MHC gene message in skeletal muscle.
- Performed Western blot analysis to detect mutant beta-myosin in skeletal muscle.
- Conducted in vitro motility assays to assess actin filament translocation by mutant beta-myosin.
Main Results:
- Mutant beta-MHC gene message was detected in the skeletal muscle of HCM patients.
- Mutant beta-myosin protein was confirmed to be present in skeletal muscle.
- Mutant beta-myosin exhibited slower translocation of actin filaments compared to normal controls in vitro.
- Identified abnormal actomyosin interactions due to single amino acid changes in beta-myosin.
Conclusions:
- Missense mutations in the beta-MHC gene are a primary cause of hypertrophic cardiomyopathy.
- Specific amino acid alterations in beta-myosin lead to dysfunctional actomyosin interactions.
- Skeletal muscle expression of mutant beta-MHC provides insights into HCM pathogenesis.
Abstract:
Hypertrophic cardiomyopathy is an important inherited disease. The phenotype has been linked, in some kindreds, to the beta-myosin heavy chain (beta-MHC) gene. Missense and silent mutations in the beta-MHC gene were used as markers to demonstrate the expression of mutant and normal cardiac beta-MHC gene message in skeletal muscle of hypertrophic cardiomyopathy patients. Mutant beta-myosin, also shown to be present in skeletal muscle by Western blot analysis, translocated actin filaments slower than normal controls in an in vitro motility assay. Thus, single amino acid changes in beta-myosin result in abnormal actomyosin interactions, confirming the primary role of missense mutations in beta-MHC gene in the etiology of hypertrophic cardiomyopathy.
Related Concept Videos
Structure of Cardiac Muscles
Compared to skeletal muscles, cardiac muscle cells are small and mostly have a single nucleus. Additionally, they are usually...
Specialized Characteristics of Cardiac Muscles
Cardiac muscle cells are smaller than skeletal muscles, averaging 10–20 mm in diameter and 50–100 mm in length. However, they have large energy demands for continuous contraction and relaxation. This energy is almost exclusively derived from aerobic metabolism of energy reserves in...
Myocarditis I: Introduction
Cardiomyopathy I: Introduction and Classification
Cardiomyopathy II: Dilated Cardiomyopathy
Cardiomyopathy III: Hypertrophic Cardiomyopathy

